What You Should Know:
– Centivax, a biotech company developing durable, universal vaccines, today announced the close of a $45 million Series A led by Steve Jurvetson’s Future Ventures, with participation from NFX, BOLD Capital, Base4,…
Continue Reading
What You Should Know:
– Viome, a pioneer in microbiome health science and personalized health solutions, today announced a $25 million internal Series D with participation from Khosla Ventures, Bold Capital WRG Ventures, Marc Benioff, and…
Continue Reading
What You Should Know:
– Openwater, a pioneering healthcare technology company, today announced the acceleration of its plans to commercialize its groundbreaking platform that leverages semiconductor physics, light, and sound to diagnose and treat diseases…
Continue Reading
Additional Financing Supports the Further Development of its Suite of Advanced Personalized Health Tests and Expansion into Key Nationwide Retailers such as CVS
Viome Life Sciences, a longevity company committed to translating scientific advancements into…
